PO.CL01.13 · 临床研究

通过单细胞全转录组成像解码浸润性导管癌中的癌症标志

Decoding cancer hallmarks through single-cell whole transcriptome imaging in invasive ductal carcinoma

海报缩略图:通过单细胞全转录组成像解码浸润性导管癌中的癌症标志
编号 3974 展板 25 时间 4/20 02:00–05:00 区域 Section 49 主讲 Patrick Danaher, PhD
分会场 Spatial Proteomics and Transcriptomics 2
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Claire Williams, Patrick Danaher, Megan Vandenberg, Martin Shelton, Mirko Corselli, Christine Kang, John Lyssand, Joseph Beechem

Bruker Spatial Biology, Seattle, WA

摘要 Abstract

中文摘要
肿瘤对微环境应激源的适应是免疫逃逸、代谢改变、血管生成和不受控增殖等关键癌症标志的基础。然而,这些适应在完整组织中的空间组织和细胞类型特异性仍缺乏充分表征。为解决这一问题,我们使用 CosMx Spatial Molecular Imager(SMI)上的 CosMx® 全转录组检测,生成了一份 II 级 HER2+ 浸润性导管癌的空间分辨单细胞转录组图谱。我们在约 1 cm² 的 FFPE 肿瘤切片内检测了超过 600,000 个细胞。空间域图谱绘制和细胞分类识别出 37 种不同的肿瘤、免疫及其他基质亚型。拷贝数分析揭示了两个肿瘤叶之间的克隆分化以及五个转录上截然不同的恶性细胞簇,提示存在空间受限的进化轨迹。 为研究免疫逃逸,我们表征了占细胞 7.3% 的强大 T 细胞浸润。空间和转录分析揭示,细胞毒性 CD8+ T 细胞在进入肿瘤后丧失效应功能并启动耗竭程序。肿瘤细胞则以局部激活 JAK-STAT、MHC-I 和 NF-κB 信号作为响应,提示对免疫攻击存在协调一致的抵抗。这些发现凸显了空间组织化的免疫抑制,并识别出可能导致 HER2+ 乳腺癌中 T 细胞功能障碍的候选机制。 接下来,我们通过对基因表达相对于血管邻近度进行建模,评估了肿瘤诱导的代谢重编程和血管生成。缺氧相关基因(如 HILPDA、VEGFA)在远离血管的区域富集,而营养相关基因(如 AZGP1、PLA2G2A)则定位于血管附近。ELF3——一种与 HER2+ 癌症不良预后相关的转录因子——出乎意料地在缺氧区上调。细胞周期分析揭示了具有应激源特异性转录谱的低增殖区域,提示存在局部生长限制。 该数据集展示了亚细胞全转录组成像在直接于组织背景中解析标志性癌症行为方面的强大能力。该数据集可被重新用于探究任何/所有癌症标志,甚至包括尚未被发现的标志。尽管源自单个 HER2+ 乳腺癌样本,但我们提出的将空间背景与单细胞分辨率相整合的分析框架,可作为未来研究的模板,用于探究不同样本和临床背景下患者特异性的肿瘤对微环境应激源的适应。
查看英文原文 English abstract
Tumor adaptation to microenvironmental stressors underlies key cancer hallmarks, including immune evasion, altered metabolism, angiogenesis, and uncontrolled proliferation. However, the spatial organization and cell-type specificity of these adaptations remain poorly characterized in intact tissue. To address this, we generated a spatially resolved, single-cell transcriptomic map of a grade II HER2+ invasive ductal carcinoma using the CosMx® Whole Transcriptome assay on the CosMx Spatial Molecular Imager (SMI). We assayed over 600,000 cells within a ~1 cm² FFPE tumor section. Spatial domain mapping and cell classification identified 37 distinct tumor, immune, and other stromal subtypes. Copy number analysis revealed clonal divergence across two tumor lobes and five transcriptionally distinct malignant clusters, suggesting spatially restricted evolutionary trajectories. To investigate immune evasion, we characterized a robust T-cell infiltrate comprising 7.3% of cells. Spatial and transcriptional analyses revealed cytotoxic CD8+ T cells losing effector function and initiating exhaustion programs upon tumor entry. Tumor cells responded with localized activation of JAK-STAT, MHC-I, and NF-κB signaling, suggesting coordinated resistance to immune attack. These findings highlight spatially organized immune suppression and identify candidate mechanisms that may contribute to T-cell dysfunction in HER2+ breast cancer. Next, we assessed tumor-induced metabolic reprogramming and angiogenesis, by modeling gene expression relative to vascular proximity. Hypoxia-related genes (e.g., HILPDA, VEGFA) were enriched in vessel-distal regions, while nutrient-associated genes (e.g., AZGP1, PLA2G2A) localized near vasculature. ELF3, a transcription factor associated with poor prognosis in HER2+ cancers, was unexpectedly upregulated in hypoxic zones. Cell cycle analysis revealed low-proliferation regions with stressor-specific transcriptional profiles, indicating localized growth constraints. This dataset showcases the power of subcellular whole transcriptome imaging in resolving hallmark cancer behaviors directly within tissue context. This same data set could be re-interrogated for any/all of the hallmarks of cancer, even those that haven't been discovered yet. While derived from a single HER2+ breast cancer sample, the analytical framework we present, integrating spatial context with single-cell resolution, serves as a template for future studies investigating patient-specific tumor adaptations to microenvironmental stressors across diverse samples and clinical settings.
利益披露 Disclosure
C. Williams, bruker spatial biology Employment. P. Danaher, bruker spatial biology Employment, Stock. M. Vandenberg, bruker Employment, Stock. M. Shelton, bruker Employment, Stock. M. Corselli, bruker Employment, Stock. C. Kang, BRUKER Employment, Stock. J. Lyssand, bruker Employment, Stock. J. Beechem, bruker Employment, Stock, Patent.

← 返回 AACR 2026 检索